These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2807561)
1. [Enoxacin concentrations in serum and in the wall of the colon during colorectal surgery]. Wenzel M; Sörgel F; Muth P; Kraeft H Infection; 1989; 17 Suppl 1():S27-9. PubMed ID: 2807561 [TBL] [Abstract][Full Text] [Related]
3. [Enoxacin concentration in bone tissue]. Adam D; Weismeier K; Sörgel F; Zürcher J Infection; 1989; 17 Suppl 1():S25-6. PubMed ID: 2807560 [TBL] [Abstract][Full Text] [Related]
4. [Enoxacin concentration in seminal fluid, in prostate secretions and in prostatic adenoma tissue following oral administration or intravenous infusion]. Naber KG; Sörgel F; Kees F; Schumacher H; Sigl G; Zürcher J; Berger S Infection; 1989; 17 Suppl 1():S30-6. PubMed ID: 2478481 [TBL] [Abstract][Full Text] [Related]
5. [The diffusion of enoxacin into the prostatic fluid in the chronic prostatitis patient]. Tanaka K; Nakano Y; Ono Y; Hirabayashi S; Yamada S Hinyokika Kiyo; 1988 Nov; 34(11):2067-9. PubMed ID: 3242374 [TBL] [Abstract][Full Text] [Related]
6. [A study on enoxacin concentration in human prostatic tissue]. Kitamura Y; Kataumi Z; Nakamura T; Takeda H Hinyokika Kiyo; 1990 Jan; 36(1):101-2. PubMed ID: 1689927 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections. Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B Infection; 1986; 14 Suppl 3():S203-8. PubMed ID: 3463543 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections. Marchbanks CR; Mikolich DJ; Mayer KH; Zinner SH; Dudley MN Antimicrob Agents Chemother; 1990 Oct; 34(10):1966-72. PubMed ID: 2291662 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections. Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B Infection; 1985; 13(5):219-24. PubMed ID: 2933340 [TBL] [Abstract][Full Text] [Related]
10. Single-dose amoxycillin-clavulanic acid vs. cefotetan for prophylaxis in elective colorectal surgery: a multicentre, prospective, randomized study. The PRODIGE Group. Arnaud JP; Bellissant E; Boissel P; Carlet J; Chastang C; Lafaix C; Rio Y; Berganeschi R J Hosp Infect; 1992 Nov; 22 Suppl A():23-32. PubMed ID: 1362746 [TBL] [Abstract][Full Text] [Related]
11. A double-blind comparative trial of short-term orally administered enoxacin in the prevention of urinary infection after elective transurethral prostatectomy: a clinical and pharmacokinetic study. Desai KM; Abrams PH; White LO J Urol; 1988 Jun; 139(6):1232-4. PubMed ID: 2453683 [TBL] [Abstract][Full Text] [Related]
12. In vivo diffusion of enoxacin in healthy renal and adenomatous prostate tissue in man. Charton M; Timbal Y Eur Urol; 1990; 17(3):252-6. PubMed ID: 1693576 [TBL] [Abstract][Full Text] [Related]
20. Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections. Patel SS; Spencer CM Drugs; 1996 Jan; 51(1):137-60. PubMed ID: 8741236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]